102 related articles for article (PubMed ID: 12119441)
21. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
22. [Systematic review about the usefulness and prognostic value of the p53 oncoprotein and proliferation marker Ki-67 for upper urinary tract transitional cell carcinoma].
Moreno Sierra J; Fernández Pérez C; Mazuecos López MP; López García J; Barreales Tolosa L; Fernández Montarroso L; López Corral JC; Blanco Jiménez E; Silmi Moyano A
Arch Esp Urol; 2004 Apr; 57(3):327-35. PubMed ID: 15174511
[TBL] [Abstract][Full Text] [Related]
23. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Orsola I
Urology; 2005 Jan; 65(1):49-54. PubMed ID: 15667862
[TBL] [Abstract][Full Text] [Related]
24. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
25. The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.
Wu TT; Chen JH; Lee YH; Huang JK
J Urol; 2000 Mar; 163(3):758-60. PubMed ID: 10687971
[TBL] [Abstract][Full Text] [Related]
26. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases.
Lin O; Cardillo M; Dalbagni G; Linkov I; Hutchinson B; Reuter VE
Mod Pathol; 2003 Dec; 16(12):1289-98. PubMed ID: 14681330
[TBL] [Abstract][Full Text] [Related]
27. P53, bcl-2, and Bax expression in renal cell carcinoma.
Vasavada SP; Novick AC; Williams BR
Urology; 1998 Jun; 51(6):1057-61. PubMed ID: 9609655
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
[TBL] [Abstract][Full Text] [Related]
29. Expression of the apoptosis-related genes Bcl-2 and p53 in clinical samples from endometrial carcinoma patients.
González-Rodilla I; Verna V; Muñoz AB; Estévez J; Boix M; Schneider J
Anticancer Res; 2011 Dec; 31(12):4191-3. PubMed ID: 22199279
[TBL] [Abstract][Full Text] [Related]
30. Significance of Ki-67 and p53 immunoexpression in the differential diagnosis of oral necrotizing sialometaplasia and squamous cell carcinoma.
Dadfarnia T; Mohammed BS; Eltorky MA
Ann Diagn Pathol; 2012 Jun; 16(3):171-6. PubMed ID: 22197541
[TBL] [Abstract][Full Text] [Related]
31. p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder.
Asci R; Yildiz L; Sarikaya S; Buyukalpelli R; Yilmaz AF; Kandemir B
Urol Int; 2001; 67(1):34-40. PubMed ID: 11464113
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of Ki-67 expression in advanced prostate cancers in relation to disease progression after androgen ablation.
Matsuura H; Hayashi N; Kawamura J; Shiraishi T; Yatani R
Eur Urol; 2000 Feb; 37(2):212-7. PubMed ID: 10705201
[TBL] [Abstract][Full Text] [Related]
33. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
[TBL] [Abstract][Full Text] [Related]
34. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
Ohmura Y; Aoe M; Andou A; Shimizu N
Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence.
Turan M; Turan G
Eur J Ophthalmol; 2020 Nov; 30(6):1232-1237. PubMed ID: 32703006
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of Ki-67, p53 and Bcl-2 expression related to histological features in gastroesophageal reflux disease.
Ayhan S; Nalbant OA; Isisag A; Türkel Küçükmetın N; Temız P
Turk J Gastroenterol; 2010 Sep; 21(3):199-205. PubMed ID: 20931420
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation.
Pillai MR; Kesari AL; Chellam VG; Madhavan J; Nair P; Nair MK
Pathol Res Pract; 1998; 194(8):549-57. PubMed ID: 9779489
[TBL] [Abstract][Full Text] [Related]
40. p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
Ioakim-Liossi A; Pantazopoulos D; Karakitsos P; Athanassiadou P; Aroni K; Giahnaki AE; Athanassiades P
Anal Quant Cytol Histol; 2000 Jun; 22(3):223-8. PubMed ID: 10872039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
